aibioTMCI TREACE MEDICAL CONCEPTS, INC.
TREACE MEDICAL CONCEPTS, INC. (TMCI) news
TREACE MEDICAL CONCEPTS, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TMCI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest TREACE MEDICAL CONCEPTS, INC. news
We have not published a story on TREACE MEDICAL CONCEPTS, INC. yet. When there is news, it will appear here.
TREACE MEDICAL CONCEPTS, INC. annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $212.7 million | $209.4 million |
| Research and development | $20.3 million | $20.6 million |
| Net income (loss) | -$59.0 million | -$55.7 million |
| Cash from operations | -$16.0 million | -$37.2 million |
| Cash and equivalents | $10.7 million | $11.3 million |
| Short-term investments | $37.7 million | $64.3 million |
Questions about TREACE MEDICAL CONCEPTS, INC.
What is the ticker symbol of TREACE MEDICAL CONCEPTS, INC.?
TREACE MEDICAL CONCEPTS, INC. trades under the ticker TMCI on NASDAQ.
Where is TREACE MEDICAL CONCEPTS, INC. listed?
TREACE MEDICAL CONCEPTS, INC. is listed on NASDAQ.
Which country or territory is TREACE MEDICAL CONCEPTS, INC. listed under?
Our directory records TREACE MEDICAL CONCEPTS, INC. under United States.
Does aibio.space cover TREACE MEDICAL CONCEPTS, INC.?
aibio.space lists TREACE MEDICAL CONCEPTS, INC. among 2,820 public biotech companies and publishes its news here as stories appear.
What was TREACE MEDICAL CONCEPTS, INC.'s revenue last year?
$212.7 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is TREACE MEDICAL CONCEPTS, INC. profitable?
TREACE MEDICAL CONCEPTS, INC. reported a net loss of $59.0 million for the fiscal year ended Dec 31, 2025, and used $16.0 million of cash in operations, per its annual report to the SEC.
How much does TREACE MEDICAL CONCEPTS, INC. spend on research and development?
$20.3 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does TREACE MEDICAL CONCEPTS, INC. have?
$45.6 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: TREACE MEDICAL CONCEPTS, INC.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- TREACE MEDICAL CONCEPTS, INC.
- Ticker
- TMCI
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction